These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4700009)

  • 1. Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
    Hunyor SN; Hansson L; Harrison TS; Hoobler SW
    Br Med J; 1973 Apr; 2(5860):209-11. PubMed ID: 4700009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management.
    Hansson L; Hunyor SN; Julius S; Hoobler SW
    Am Heart J; 1973 May; 85(5):605-10. PubMed ID: 4697628
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood pressure over-shoot due to acute clonidine (Catapres) withdrawal: studies on arterial and urinary catecholamines and suggestions for management of the crisis.
    Hansson L; Hunyor SN
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():181s-3. PubMed ID: 4150271
    [No Abstract]   [Full Text] [Related]  

  • 4. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
    Reid JL; Wing LM; Dargie HJ; Hamilton CA; Davies DS; Dollery CT
    Lancet; 1977 Jun; 1(8023):1171-4. PubMed ID: 68274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine withdrawal. Mechanism and frequency of rebound hypertension.
    Geyskes GG; Boer P; Dorhout Mees EJ
    Br J Clin Pharmacol; 1979 Jan; 7(1):55-62. PubMed ID: 760743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clonidine hydrochloride (Catapres). A new antihypertensive agent.
    Kosman ME
    JAMA; 1975 Jul; 233(2):174-6. PubMed ID: 1173448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial.
    Patel MB; McKenna JW; Alvarez JM; Sugiura A; Jenkins JM; Guillamondegui OD; Pandharipande PP
    Trials; 2012 Sep; 13():177. PubMed ID: 23013802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects.
    Leckman JF; Ort S; Caruso KA; Anderson GM; Riddle MA; Cohen DJ
    Arch Gen Psychiatry; 1986 Dec; 43(12):1168-76. PubMed ID: 3465278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine.
    Hamilton BP; Mersey JH; Hamilton J; Kuzbida G; Pavlis R; Levinson P
    Clin Pharmacol Ther; 1984 Nov; 36(5):628-33. PubMed ID: 6488684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine metabolism during clonidine withdrawal.
    Martin PR; Ebert MH; Gordon EK; Weingartner H; Kopin IJ
    Psychopharmacology (Berl); 1984; 84(1):58-63. PubMed ID: 6436892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrupt cessation of clonidine administration: a prospective study.
    Whitsett TL; Chrysant SG; Dillard BL; Anton AH
    Am J Cardiol; 1978 Jun; 41(7):1285-90. PubMed ID: 665535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine.
    Neusy AJ; Lowenstein J
    J Clin Pharmacol; 1989 Jan; 29(1):18-24. PubMed ID: 2708545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension.
    Strauss FG; Franklin SS; Lewin AJ; Maxwell MH
    JAMA; 1977 Oct; 238(16):1734-6. PubMed ID: 578267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative and postoperative use of clonidine with neurolept anaesthesia.
    Kaukinen S; Kaukinen L; Eerola R
    Acta Anaesthesiol Scand; 1979 Apr; 23(2):113-20. PubMed ID: 442942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.
    Rosenthal T; Rabinowitz B; Boichis H; Elazar E; Brauner A; Neufeld HN
    Eur J Clin Pharmacol; 1981; 20(4):237-40. PubMed ID: 6273179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
    Planz G; Beckenbauer U; Bundschu HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
    Vanholder R; Lamiere N; Ringoir S
    Kidney Int Suppl; 1988 Sep; 25():S181-3. PubMed ID: 2903267
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Withdrawal of antihypertensive therapy.
    Gorchien A
    Lancet; 1974 Dec; 2(7896):1576. PubMed ID: 4141019
    [No Abstract]   [Full Text] [Related]  

  • 20. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms.
    Manhem P; Nilsson LH; Moberg AL; Wadstein J; Hökfelt B
    Alcohol Clin Exp Res; 1985; 9(3):238-43. PubMed ID: 3893195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.